YIM
Moritz Fürstenau, MD
Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne
Cologne, Germany
Elżbieta Iskierka-Jażdżewska, MD, PhD
Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital in Lodz, Poland
Łódź, Lodzkie, Poland
Primary Author / Presenter: Olina Lind, MSc – Department of Oncology-Pathology, Karolinska Institutet
Primary Author / Presenter: Miguel Bastos-Boente, PhD candidate – Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
Primary Author / Presenter: Collin R. Nzunda, BSc, MPhil – Muhimbili University of Health and Allied Sciences
Primary Author / Presenter: Yuting Yan, PhD – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Primary Author / Presenter: Mohammad Al-Agil, MB BCh BAO NUI, MSc – King's College Hospital NHS Foundation Trust
Primary Author / Presenter: Aseel Alsouqi, MD – The Ohio State University
Primary Author: Huayuan Zhu, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
Co-Author / Presenter: Luomengjia Dai, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
Primary Author / Presenter: Anita Soboń – Department of Hematology, Institute of Hematology and Transfusion Medicine
